Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061319) titled 'Development of coordination between hospitals and clinics using an IBD app monitoring symptom of IBD patients' on April 20.
Study Type:
Observational
Primary Sponsor:
Institute - University of Tsukuba
Condition:
Condition - Ulcerative Colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this newly developed IBD app is to establish a system whereby patients can record their symptoms daily-such as the number of bowel movements and the frequency of bloody stools-and doctors can monitor this information. Furthermore, the aim is to establish a system of inter-hospital collaboration whereby IBD specialists at specialist hospitals can monitor patients currently receiving treatment at other hospitals and provide this information to their attending doctors.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients currently receiving treatment at the University of Tsukuba Hospital or the Tsukuba Gastroenterology and Endoscopy Clinic
2. Patients diagnosed with ulcerative colitis
3. Patients aged 18 or over
4. Patients who are able to install the IBD app on a smart device
Key exclusion criteria - those deemed inappropriate by the researchers
Target Size - 500
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 07 Month 16 Day
Date of IRB - 2025 Year 07 Month 16 Day
Anticipated trial start date - 2026 Year 04 Month 21 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070159
Disclaimer: Curated by HT Syndication.
